報價延遲最少15分鐘:2025/01/21 08:43 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
11.97 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.98/--
|
|
企業價值
426.26M
|
| 資產負債 |
|
每股賬面淨值
0.33
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
65.42M
|
|
每股收益
2.02
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 08:43 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System. |